Memory performance is related to amyloid and tau pathology in the hippocampus
- PMID: 19258354
- PMCID: PMC2785022
- DOI: 10.1136/jnnp.2008.154146
Memory performance is related to amyloid and tau pathology in the hippocampus
Abstract
Objective: To determine the relation of amyloid and tau pathology in the hippocampal formation to decline in memory and other cognitive functions in Alzheimer's disease (AD).
Methods: Regression models were used to relate semiquantitative measurements of amyloid plaques, neurofibrillary tangles (NFTs) and neuropil threads (NTs) at autopsy with antemortem performance in memory, abstract/visuospatial and language domains in two independent samples (n = 41, n = 66) that had repeated neuropsychological measurements before death.
Results: In both groups, the number of NFTs in the entorhinal cortex, subiculum and CA1 region was inversely associated with memory performance at the last visit before death. However, the number of amyloid plaques and NTs in the entorhinal cortex was also inversely related to poor memory function. Moreover, as the number of plaques or NTs increased in any region of the hippocampal formation, there was a more rapid decline in memory performance over time; a similar decline was associated with increasing numbers of NFTs in the CA1 or subiculum. In contrast, there was no association between amyloid plaques, NFTs or NTs in the frontal or parietal lobe and performance in memory, nor was there an association between plaques, NFTs or NTs in the hippocampal formation and cognitive functions unrelated to memory.
Discussion: This study implicates both amyloid deposition and tau pathology in the hippocampus as an early and late cause of decline in memory function over time in AD. Memory performance appears to be specifically related to the amount of amyloid plaques, NFTs and NTs in the entorhinal cortex and hippocampus.
Figures



Comment in
-
What is the molecular pathology that underlies hippocampal memory decline?J Neurol Neurosurg Psychiatry. 2009 Jul;80(7):703. doi: 10.1136/jnnp.2008.163907. J Neurol Neurosurg Psychiatry. 2009. PMID: 19531682 No abstract available.
Similar articles
-
Activation of caspase-6 in aging and mild cognitive impairment.Am J Pathol. 2007 Apr;170(4):1200-9. doi: 10.2353/ajpath.2007.060974. Am J Pathol. 2007. PMID: 17392160 Free PMC article.
-
Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging.J Neurosci. 2018 Jan 17;38(3):530-543. doi: 10.1523/JNEUROSCI.2028-17.2017. Epub 2017 Nov 30. J Neurosci. 2018. PMID: 29192126 Free PMC article.
-
Visual association pathology in preclinical Alzheimer disease.J Neuropathol Exp Neurol. 2006 Jun;65(6):621-30. doi: 10.1097/00005072-200606000-00010. J Neuropathol Exp Neurol. 2006. PMID: 16783172
-
Amyloid-beta, tau, and dementia.J Alzheimers Dis. 2009;17(4):729-36. doi: 10.3233/JAD-2009-1090. J Alzheimers Dis. 2009. PMID: 19542626 Review.
-
Alzheimer's Disease Neuropathological Change in Aged Non-Primate Mammals.Int J Mol Sci. 2024 Jul 25;25(15):8118. doi: 10.3390/ijms25158118. Int J Mol Sci. 2024. PMID: 39125687 Free PMC article. Review.
Cited by
-
The role of astrocyte mitochondria in differential regional susceptibility to environmental neurotoxicants: tools for understanding neurodegeneration.Toxicol Sci. 2015 Mar;144(1):7-16. doi: 10.1093/toxsci/kfu254. Toxicol Sci. 2015. PMID: 25740792 Free PMC article. Review.
-
The effects of microglia on tauopathy progression can be quantified using Nexopathy in silico (Nexis) models.Sci Rep. 2022 Dec 7;12(1):21170. doi: 10.1038/s41598-022-25131-3. Sci Rep. 2022. PMID: 36477076 Free PMC article.
-
A method for inferring regional origins of neurodegeneration.Brain. 2018 Mar 1;141(3):863-876. doi: 10.1093/brain/awx371. Brain. 2018. PMID: 29409009 Free PMC article.
-
Impact of genetic variation in SORCS1 on memory retention.PLoS One. 2011;6(10):e24588. doi: 10.1371/journal.pone.0024588. Epub 2011 Oct 26. PLoS One. 2011. PMID: 22046233 Free PMC article.
-
Biomarkers of Alzheimer's disease: from central nervous system to periphery?Int J Alzheimers Dis. 2010 Dec 20;2011:342980. doi: 10.4061/2011/342980. Int J Alzheimers Dis. 2010. PMID: 21197431 Free PMC article.
References
-
- Braak H, Braak E. Staging of Alzheimer’s disease-related neurofibrillary changes. Neurobiol Aging. 1995;16(3):271–8. discussion 278-84. - PubMed
-
- deToledo-Morrell L, Stoub TR, Bulgakova M, et al. MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD. Neurobiol Aging. 2004;25(9):1197–203. - PubMed
-
- Tang MX, Stern Y, Marder K, et al. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. Jama. 1998;279(10):751–5. - PubMed
-
- Stern Y, Andrews H, Pittman J, et al. Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol. 1992;49(5):453–60. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous